New advances have reinforced our understanding of respiratory disease as a complex interaction between environment, genetic predisposition and host responses.1 We describe recent advances in diseases that are a major cause of morbidity and mortality.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Respiratory Unit, Division of Medicine, Cardiac and Critical Care Services, Flinders Medical Centre and Flinders University, Bedford Park, SA.
Correspondence: jack.alpers@flinders.edu.au
- 1. Crystal RG. Research opportunities and advances in lung disease. JAMA 2001; 285: 612-618.
- 2. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
- 3. Anzueto A, Angel L. Update in pulmonary disease. Ann Intern Med 2000; 133: 360-366.
- 4. Roche N. Recent advances: pulmonary medicine. BMJ 1999; 318: 171-176.
- 5. Jefferson T, Demicheli V, Deeks J, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults [systematic review] The Cochrane Library, Issue 4, 2001. Oxford: Update Software. Updated quarterly.
Online responses are no longer available. Please refer to our instructions for authors page for more information.